123 related articles for article (PubMed ID: 7605434)
1. Life-threatening human parvovirus B19 infection in immunocompetent haemophilia.
Yee TT; Lee CA; Pasi KJ
Lancet; 1995 Mar; 345(8952):794-5. PubMed ID: 7605434
[No Abstract] [Full Text] [Related]
2. [Severe parvovirus B19 infection in an immunocompetent child with hemophilia A].
Coumau E; Peynet J; Harzic M; Béal G; Castaigne S; Leverger G; Foucaud P
Arch Pediatr; 1996 Jan; 3(1):35-9. PubMed ID: 8745824
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 antibodies in patients with haemophilia A.
Peerlinck K; Goubau P; Reybrouck R; Desmyter J; Vermylen J
Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
[No Abstract] [Full Text] [Related]
4. Virus infection and clotting factor concentrates.
Evans DI
Lancet; 1995 May; 345(8959):1247-8. PubMed ID: 7739337
[No Abstract] [Full Text] [Related]
5. Parvovirus B19 and blood products.
Prowse CV
Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909119
[No Abstract] [Full Text] [Related]
6. Parvovirus B19 and blood products.
Guillaume T
Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909118
[No Abstract] [Full Text] [Related]
7. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
[TBL] [Abstract][Full Text] [Related]
8. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
Yee TT; Cohen BJ; Pasi KJ; Lee CA
Br J Haematol; 1996 May; 93(2):457-9. PubMed ID: 8639448
[TBL] [Abstract][Full Text] [Related]
9. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
Lefrère JJ; Mariotti M; Thauvin M
Lancet; 1994 Jan; 343(8891):211-2. PubMed ID: 7904670
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of human parvovirus B19 DNA contamination of factor VIII products.
Matsunaga Y
Dev Biol Stand; 1996; 88():217. PubMed ID: 9119140
[No Abstract] [Full Text] [Related]
11. [Virus in hemophilia: current status and future perspectives].
Aguilar C; Félix Lucía J
Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
[No Abstract] [Full Text] [Related]
12. Eliminating parvovirus B19 from blood products.
Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M
Lancet; 1994 Mar; 343(8900):798. PubMed ID: 7907759
[No Abstract] [Full Text] [Related]
13. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
[TBL] [Abstract][Full Text] [Related]
15. Frequent human parvovirus B19 DNA occurrence and high seroprevalence in haemophilic patients from a non-metropolitan blood centre, Brazil.
Slavov SN; Kashima S; Rocha-Junior MC; Oliveira LC; Silva-Pinto AC; Yamamoto AY; Covas DT
Transfus Med; 2014 Apr; 24(2):130-2. PubMed ID: 24684574
[No Abstract] [Full Text] [Related]
16. Virus infection and clotting factor concentrates.
Rubinstein DB
Lancet; 1995 May; 345(8959):1248. PubMed ID: 7739339
[No Abstract] [Full Text] [Related]
17. Transfusion-transmitted disease.
Lee CA
Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates.
Azzi A; Ciappi S; Zakvrzewska K; Morfini M; Mariani G; Mannucci PM
Am J Hematol; 1992 Mar; 39(3):228-30. PubMed ID: 1312304
[TBL] [Abstract][Full Text] [Related]
19. Acute hepatitis A in patients with haemophilia A.
Peerlinck K; Vermylen J
Lancet; 1993 Jan; 341(8838):179. PubMed ID: 8093776
[No Abstract] [Full Text] [Related]
20. Human parvovirus B19 infection in persons with haemophilia.
Prowse C; Dow B; Pelly SJ; McIntosh E; Reading S; Lowe GD; Gibson B; Cachia P; Thomas A; Dennis R; Ludlam CA
Thromb Haemost; 1998 Aug; 80(2):351. PubMed ID: 9716173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
